261 related articles for article (PubMed ID: 15117744)
1. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.
Cosgrove GP; Brown KK; Schiemann WP; Serls AE; Parr JE; Geraci MW; Schwarz MI; Cool CD; Worthen GS
Am J Respir Crit Care Med; 2004 Aug; 170(3):242-51. PubMed ID: 15117744
[TBL] [Abstract][Full Text] [Related]
2. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
3. Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
Yasuda T; Fukuda-Tani M; Nihira T; Wada K; Hattori N; Mizuno Y; Mochizuki H
Exp Neurol; 2007 Aug; 206(2):308-17. PubMed ID: 17604022
[TBL] [Abstract][Full Text] [Related]
4. The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis.
Cao B; Guo Z; Zhu Y; Xu W
Chin Med J (Engl); 2000 Sep; 113(9):776-82. PubMed ID: 11776068
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and pulmonary fibrosis: feast or famine?
Keane MP
Am J Respir Crit Care Med; 2004 Aug; 170(3):207-9. PubMed ID: 15280169
[No Abstract] [Full Text] [Related]
6. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
[TBL] [Abstract][Full Text] [Related]
8. Altered pigment epithelium-derived factor and vascular endothelial growth factor levels in lymphangioma pathogenesis and clinical recurrence.
Sidle DM; Maddalozzo J; Meier JD; Cornwell M; Stellmach V; Crawford SE
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):990-5. PubMed ID: 16301371
[TBL] [Abstract][Full Text] [Related]
9. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
10. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
Matsumoto K; Ishikawa H; Nishimura D; Hamasaki K; Nakao K; Eguchi K
Hepatology; 2004 Jul; 40(1):252-9. PubMed ID: 15239109
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells.
Takenaka K; Yamagishi S; Jinnouchi Y; Nakamura K; Matsui T; Imaizumi T
Life Sci; 2005 Nov; 77(25):3231-41. PubMed ID: 15985268
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor.
Liakouli V; Elies J; El-Sherbiny YM; Scarcia M; Grant G; Abignano G; Derrett-Smith EC; Esteves F; Cipriani P; Emery P; Denton CP; Giacomelli R; Mavria G; Del Galdo F
Ann Rheum Dis; 2018 Mar; 77(3):431-440. PubMed ID: 29259049
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease.
Rychli K; Huber K; Wojta J
Expert Opin Ther Targets; 2009 Nov; 13(11):1295-302. PubMed ID: 19694500
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Oncol Rep; 2005 Dec; 14(6):1615-9. PubMed ID: 16273265
[TBL] [Abstract][Full Text] [Related]
17. Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Shimizu K; Takegami Y; Shimizu T; Inoue H; Imaizumi T
Microvasc Res; 2006 May; 71(3):222-6. PubMed ID: 16624340
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.
Garcia M; Fernandez-Garcia NI; Rivas V; Carretero M; Escamez MJ; Gonzalez-Martin A; Medrano EE; Volpert O; Jorcano JL; Jimenez B; Larcher F; Del Rio M
Cancer Res; 2004 Aug; 64(16):5632-42. PubMed ID: 15313901
[TBL] [Abstract][Full Text] [Related]
19. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
[TBL] [Abstract][Full Text] [Related]
20. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
Ek ET; Dass CR; Contreras KG; Choong PF
Cancer Gene Ther; 2007 Jul; 14(7):616-26. PubMed ID: 17479108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
